AU2004205785A8 - Kinases and GPCRs involved in apoptosis - Google Patents

Kinases and GPCRs involved in apoptosis

Info

Publication number: AU2004205785A8
Authority: AU; Australia
Prior art keywords: kinases; apoptosis; gpcrs involved; gpcrs; involved
Prior art date: 2003-01-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2004205785A

Other versions

AU2004205785A1 (en

Inventor

Ian Hayes

Finbarr Murphy

Liam Seery

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

EiRx Therapeutics Ltd

Original Assignee

EiRx Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-23

Filing date

2004-01-23

Publication date

2004-08-05

2003-01-23 Priority claimed from GBGB0301566.6A external-priority patent/GB0301566D0/en

2004-01-23 Application filed by EiRx Therapeutics Ltd filed Critical EiRx Therapeutics Ltd

2004-08-05 Publication of AU2004205785A1 publication Critical patent/AU2004205785A1/en

2004-08-05 Publication of AU2004205785A8 publication Critical patent/AU2004205785A8/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Cell Biology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Physiology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hospice & Palliative Care (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU2004205785A 2003-01-23 2004-01-23 Kinases and GPCRs involved in apoptosis Abandoned AU2004205785A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB0301566.6A GB0301566D0 (en)	2003-01-23	2003-01-23	Kinasaes and GPCRs involved in apoptosis
GB0301566.6		2003-01-23
US45753303P	2003-03-25	2003-03-25
US60/457,533		2003-03-25
PCT/GB2004/000271 WO2004065959A2 (en)	2003-01-23	2004-01-23	Kinases and gpcrs involved in apoptosis

Publications (2)

Publication Number	Publication Date
AU2004205785A1 AU2004205785A1 (en)	2004-08-05
AU2004205785A8 true AU2004205785A8 (en)	2004-08-05

Family

ID=32773972

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2004205785A Abandoned AU2004205785A1 (en)	2003-01-23	2004-01-23	Kinases and GPCRs involved in apoptosis

Country Status (5)

Country	Link
EP (1)	EP1588163A2 (en)
JP (1)	JP2006518590A (en)
AU (1)	AU2004205785A1 (en)
CA (1)	CA2513148A1 (en)
WO (1)	WO2004065959A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0328928D0 (en) *	2003-12-12	2004-01-14	Cancer Rec Tech Ltd	Materials and methods relating to cell cycle control
CA2555675A1 (en) *	2004-02-10	2005-08-25	Trustees Of Dartmouth College	Nicotinamide riboside kinase compositions and methods for using the same
US7306923B2 (en) *	2004-06-14	2007-12-11	Galapagos N.V.	Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
US20060211004A1 (en) *	2005-02-15	2006-09-21	Ilsley Diane D	Methods and compositions for determining non-specific cytotoxicity of a transfection agent
JP4854334B2 (en) *	2006-03-06	2012-01-18	三洋電機株式会社	Real-time detection device for nucleic acid amplification products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6500938B1 (en) *	1998-01-30	2002-12-31	Incyte Genomics, Inc.	Composition for the detection of signaling pathway gene expression
GB9807848D0 (en) *	1998-04-09	1998-06-10	Medical Res Council	Assay method and means
WO2001046468A2 (en) *	1999-12-21	2001-06-28	Eirx Therapeutics Ltd	Screening method for ros-induced apoptosis in a cell
WO2002004657A2 (en) *	2000-07-07	2002-01-17	Eirx Therapeutics Limited	Screening method
JP2002139493A (en) *	2000-11-01	2002-05-17	Sumitomo Pharmaceut Co Ltd	New high-throughput screening method
GB0206861D0 (en) *	2002-03-22	2002-05-01	Glaxo Group Ltd	Medicaments

2004
- 2004-01-23 CA CA002513148A patent/CA2513148A1/en not_active Abandoned
- 2004-01-23 EP EP04704638A patent/EP1588163A2/en not_active Withdrawn
- 2004-01-23 JP JP2006500235A patent/JP2006518590A/en active Pending
- 2004-01-23 WO PCT/GB2004/000271 patent/WO2004065959A2/en not_active Ceased
- 2004-01-23 AU AU2004205785A patent/AU2004205785A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004065959A3 (en)	2004-11-25
WO2004065959A2 (en)	2004-08-05
EP1588163A2 (en)	2005-10-26
AU2004205785A1 (en)	2004-08-05
JP2006518590A (en)	2006-08-17
CA2513148A1 (en)	2004-08-05

Publication	Publication Date	Title
AU2003215460A1 (en)	2003-10-13	Cancer associated protein kinases and their uses
AU2003287663A1 (en)	2005-05-19	Mram and methods for reading the mram
WO2005110261A8 (en)	2006-03-16	Enhanced systems and methods for rf-induced hyperthermia
AU2003242247A1 (en)	2004-11-26	Bone implant that can be screwed in
AU2002364051A1 (en)	2003-09-02	Anti-cancer combination and use thereof
AU2003220437A1 (en)	2003-10-08	Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AUPS198302A0 (en)	2002-06-06	Improvements in bowsprits
WO2006026027A8 (en)	2006-08-17	Markers of alterations in the y chromosome and uses therefor
AU2003298810A1 (en)	2004-08-23	NF-kB INHIBITORS AND USES THEREOF
AU2004205785A8 (en)	2004-08-05	Kinases and GPCRs involved in apoptosis
AU2003245627A1 (en)	2004-01-06	Kinases and phosphatases
AU2003242405A1 (en)	2004-12-13	Compounds and preparaitons having antiviral effect
GB0301566D0 (en)	2003-02-26	Kinasaes and GPCRs involved in apoptosis
GB0305267D0 (en)	2003-04-09	Proteins involved in apoptosis
AU2003287427A1 (en)	2004-06-07	Kinases and phosphatases
AU2003262856A1 (en)	2004-03-11	Kinases and phosphatases
AU2003231531A1 (en)	2003-11-10	Kinases and phosphatases
AU2003236091A1 (en)	2003-10-27	Caffeine synthase and use thereof
AU2003218321A1 (en)	2003-10-08	Kinases and phosphatases
AU2003254037A1 (en)	2004-02-09	Kinases and phosphatases
AU2004900982A0 (en)	2004-03-11	Antiviral Host Factors and Methods
GB0318162D0 (en)	2003-09-03	Polishes and their uses
AU2003907165A0 (en)	2004-01-15	Improvements in sponges
GB0305268D0 (en)	2003-04-09	Proteins involved in apoptosis
GB0305269D0 (en)	2003-04-09	Proteins involved in apoptosis

Legal Events

Date	Code	Title	Description
2005-08-18	TH	Corrigenda	Free format text: IN VOL 19, NO 29, PAGE(S) 1940 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME EIRX THERAPEUTICS LIMITED., APPLICATION NO. 2004205785, UNDER INID (72) CORRECT THE NAME TO READ MURPHY, FINBARR; SEERY, LIAM; HAYES, IAN.
2009-08-20	MK4	Application lapsed section 142(2)(d) - no continuation fee paid for the application